• Nocodazole: Optimizing Microtubule Polymerization Inhibition

  2026-07-28

  Nocodazole stands out as a reversible, high-precision microtubule polymerization inhibitor, enabling reproducible studies in cell cycle regulation and cytoskeletal dynamics. This article delivers actionable workflow enhancements, troubleshooting tips, and insight from cutting-edge research, guiding advanced applications from cancer research to metabolism-cytoskeleton crosstalk.

• Tropifexor (LJN452): Uncovering FXR Agonist Roles in Liver F

  2026-07-27

  Explore how Tropifexor (LJN452), a potent FXR agonist, advances liver fibrosis and metabolic disease research by modulating bile acid and epithelial barrier dynamics. This article uniquely bridges translational FXR biology with recent mechanistic insights and practical assay considerations.

• Cyclophilin A Is Essential for Cyclosporin A Immunosuppressi

  2026-07-27

  This study demonstrates that the immunosuppressive effects of Cyclosporin A (CsA) depend critically on Cyclophilin A (CypA) in murine models. Mice lacking CypA exhibit resistance to CsA-mediated T-cell inhibition, highlighting CypA as the principal intracellular target mediating calcineurin inhibition and downstream immune suppression.

• Spatial Proteomics Reveals PD-L1 and IL-6 Crosstalk in PSC

  2026-07-26

  This study uses spatial proteomics and cell-cell cross-talk analysis to demonstrate a direct interaction between PD-L1 and IL-6 signaling in primary sclerosing cholangitis (PSC). The findings deepen understanding of immune regulation in PSC and highlight interlinked therapeutic targets within immune checkpoint and cytokine pathways.

• 740 Y-P: PI 3-Kinase Activator for Vesicular and Survival As

  2026-07-25

  740 Y-P stands out as a robust PI 3-kinase activator enabling precise PI3K/AKT pathway modulation for vesicular trafficking, neuronal survival, and apoptosis assays. Its high solubility in DMSO and proven reliability in cell-based workflows make it an essential tool for advanced cell signaling research.

• SGI-1027 and Everolimus Synergy in Renal Cancer Cell Death

  2026-07-24

  This study uncovers a novel cytotoxic mechanism for the DNA methyltransferase inhibitor SGI-1027, demonstrating its unique induction of methuosis and its synergistic effects with everolimus in renal cell carcinoma. The findings provide mechanistic insight into overcoming everolimus resistance and highlight the therapeutic potential of combining epigenetic modulation with mTOR inhibition.

• S Tag Peptide (A6007): Practical Guide for Fusion Tag Workfl

  2026-07-24

  The S Tag Peptide provides a highly soluble, antibody-compatible fusion tag for efficient recombinant protein detection, purification, and solubility improvement. It is best applied in aqueous workflows with anti-S-Tag antibody detection but should not be used in ethanol-based protocols or where the tag's independent enzymatic activity is required.

• Ganetespib (STA-9090) in Applied Cancer Research Workflows

  2026-07-23

  Ganetespib (STA-9090) redefines Hsp90 inhibition with high potency and selectivity, streamlining preclinical cancer models. This article delivers actionable protocols, optimization strategies, and troubleshooting insights for maximizing experimental performance in tumor growth inhibition and chaperone disruption assays.

• Targeting NUAK1-Mediated Tau Phosphorylation in Alzheimer's

  2026-07-23

  This study delineates the pathological relevance of tau phosphorylation at Ser356 in Alzheimer’s disease and demonstrates that NUAK1/2 inhibition with WZ4003 reduces p-tau Ser356 levels in brain slice cultures. The findings suggest a mechanistically distinct route to modulate tau pathology, with implications for translational models of neurodegeneration.

• Palmitic acid (Hexadecanoic Acid): Technical Protocol Guidan

  2026-07-22

  Palmitic acid (hexadecanoic acid, SKU N2456) is a high-purity saturated long-chain fatty acid for targeted in vitro research on lipid metabolism, protein palmitoylation, and metabolic disorder pathways. It should not be used in protocols requiring aqueous solubility or long-term solution stability, making careful preparation and handling critical for reproducible results.

• Topotecan and Carboplatin Regimens in Ovarian Cancer: System

  2026-07-22

  This Cochrane review rigorously evaluates the clinical benefit and toxicity profiles of adding topotecan to standard carboplatin/paclitaxel regimens in ovarian cancer. The findings clarify the impact on survival and progression, informing preclinical and translational study design.

• Patient-Derived Gastric Cancer Assembloids Advance Drug Test

  2026-07-21

  This study introduces a patient-derived gastric cancer assembloid model integrating matched tumor organoids and stromal cells, providing a physiologically relevant system for drug response analysis. The model uncovers critical roles for stromal components in modulating gene expression and therapy resistance, enhancing precision in preclinical cancer research.

• E-64: Precision Cysteine Protease Inhibition for Research

  2026-07-21

  E-64, a potent L-trans-epoxysuccinyl peptide, sets the standard for irreversible cysteine protease inhibition in mechanistic, cancer, and cell biology research. This article unpacks practical workflows, key reference advances, and troubleshooting insights to empower reproducible results across diverse experimental models.

• Angiotensin II–HIF-1α-HILPDA Axis Drives Radioresistance in

  2026-07-20

  This study uncovers how local angiotensin II sustains radioresistance in nasopharyngeal carcinoma (NPC) by suppressing ferroptosis through the HIF-1α-HILPDA axis. The mechanistic insights highlight AGT, HIF-1α, and HILPDA as biomarkers and therapeutic targets to enhance radiosensitivity in NPC.

• Antibacterial Use and Resistance in Psychiatric Hospitals Du

  2026-07-20

  A recent study provides the first detailed, quantitative analysis of antibacterial drug use and bacterial resistance patterns in a psychiatric hospital during the COVID-19 epidemic. The findings highlight relatively low antibiotic consumption but a concerning rise in resistance, underscoring the need for ongoing surveillance and evidence-based antimicrobial stewardship.

453 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page